Transient 18FDG-avid hilar lymph node on PET/CT imaging in asymptomatic COVID-19
Mahboobeh Karimi-Galougahi,
Abbas Yousefi-Koma,
Neda Khalili,
Mehrdad Bakhshayeshkaram,
Sara Haseli
Affiliations
Mahboobeh Karimi-Galougahi
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abbas Yousefi-Koma
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Neda Khalili
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Mehrdad Bakhshayeshkaram
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Sara Haseli
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran; Corresponding author.
The most common features of coronavirus disease-2019 (COVID-19) pneumonia on chest computed tomography imaging are ground glass opacity and consolidation. Mediastinal and hilar lymph node enlargement are less frequently observed. Herein, we present an unexpected finding of fluorodeoxyglucose (FDG)-avid hilar lymph node in an asymptomatic patient with COVID-19, and show that this is a transient phenomenon, subsiding on a follow-up FDG-PET/CT within 10 days.
